AstraZeneca says on track to deliver 2 million weekly shots Industry bodies cautious about changing dose regimes
LONDON, Jan 13 (Reuters) - Britain is targeting a 24-hour, 7-day a week vaccination programme as soon as possible, Prime Minister Boris Johnson said on Wednesday, as he bids to step up the pace of the rollout and give shots to at-risk groups by mid-February.
AstraZeneca executives said the company was on track to deliver 2 million doses a week before mid-February, and Johnson said the availability of more shots would be crucial to scaling up to a round-the-clock service.
“We’ll be going to 24/7 as soon as we can,” Johnson told parliament. “At the moment the limit is on supply.”
Updated / Wednesday, 13 Jan 2021
15:56 We ll be going to 24/7 as soon as we can, Boris Johnson told parliament
Britain is targeting a 24-hour, seven-day a week vaccination programme as soon as possible, Prime Minister Boris Johnson has said, as he bids to step up the pace of the rollout and give shots to at-risk groups by mid-February.
AstraZeneca executives said the company was on track to deliver 2 million doses a week before mid-February, and Mr Johnson said the availability of more shots would be crucial to scaling up to a round-the-clock service. We ll be going to 24/7 as soon as we can, Mr Johnson told parliament. At the moment the limit is on supply.
Boris Johnson says Britain will set up a 24/7 COVID-19 vaccination program ‘as soon as we can’ Alistair Smout and William James LONDON Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Jeremy Selwyn/The Associated Press
Britain is targeting a 24-hour, 7-day a week COVID-19 vaccination program as soon as possible, Prime Minister Boris Johnson said on Wednesday, as he bids to step up the pace of the rollout with daily coronavirus deaths at record levels.
2021 set to be Year of the COVID-19 vaccine but production and delivery challenges remain Toggle share menu
Advertisement
2021 set to be Year of the COVID-19 vaccine but production and delivery challenges remain
A medical staff member holds a box while simulating to carry the COVID-19 vaccine during a drill days before starting the vaccination process from the Pfizer-BioNTech COVID-19 vaccine, in Mexico City
23 Dec 2020 04:44PM (Updated:
23 Dec 2020 05:09PM) Share this content
Bookmark
ZURICH: As 2020 closes, regulatory approval of COVID-19 vaccines has raised hopes the world can defeat the pandemic next year. But production and delivery challenges suggest beating the disease will be a marathon whose finish line is still far away.